Review Article
Year: 2021 | Month: August | Volume: 11 | Issue: 8 | Pages: 137-142
DOI: https://doi.org/10.52403/ijhsr.20210820
A Review on Vaccination Drive for COVID-19 in India
Yukta1, R.K Patil2, H.C Patil3
1Pharm.D (Student), Adesh institute of Pharmacy and Biomedical Sciences, Bathinda
2Professor, Department of Pharmacy Practice, Adesh Institute of Pharmacy and Biomedical Sciences, Bathinda
3Professor & Principal, Adesh Institute of Pharmacy and Biomedical Sciences, Bathinda
Corresponding Author: Yukta
ABSTRACT
The Covid-19 pandemic is destructing the whole world rapidly and also results in changing the order of human life. Various strategies and efforts are being applied by health experts to fight against the pandemic. Various vaccines are developed by researchers of different countries. The aim for developing the vaccines is to produce Herd immunity i.e. to resist the spread of SARS-CoV-2 virus. 8-12 years are required for the development of vaccine in normal circumstances but in emergency like Covid-19 pandemic vaccines get ready in 10 months by various methods like viral vector vaccines, mRNA based vaccines, inactivated vaccines. In India only three vaccines i.e. Covaxin, Covishield, and Sputnik-V get the Emergency Use Authorisation (EUA) from the drug controller general of India (DCGI). Vaccines vary in their efficacy that’s why only few vaccines get the emergency approval across the globe. These vaccines also show mild to moderate and in some case rare adverse effects.
Key words: Pandemic, Vaccines, Covid-19, Herd immunity, Adverse effects.